Investigating prophylactic botulinum toxin type A for chronic headache disorders

Bibliography

• MATHEW NT, KAUP AO: The use of botulinum toxin type A in headache treatment. Curr. Treat. Options Neurol. (2002) 4:365-373.
   Web of Science ®Google Scholar
• ARGOFF CE: The use of botulinum toxins for chronic pain and headaches. Curr. Treat. Options Neurol. (2003) 5:483-492.
   Web of Science ®Google Scholar
• DODICK DW: Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside. Headache (2003) 43(Suppl. 1):25-33.
   Google Scholar
• EVERS S: Botulinum toxin and the management of chronic headaches. Curr. Opin. Otolaryngol. Nead Neck Surg. (2004) 12:197-203.
   Google Scholar
• BLUMENFELD AM, DODICK DW, SILBERSTEIN SD: Botulinum neurotoxin for the treatment of migraine and other primary headache disorders. Dermatol. Clin. (2004) 22:167-175.
   Google Scholar
• SCHOENEN J: Guidelines for trials of drug treatments in tension-type headache. First edition: International Headache Society Committee on Clinical Trials. Cephalalgia (1995) 15:165-179.
   PubMed Web of Science ®Google Scholar
• TFELT-HANSEN P, BLOCK G, DAHLÖF C et al.: Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 20:765-786.
   PubMed Web of Science ®Google Scholar
• HEADACHE CLASSIFICATIONCOMMITTEE: New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 26:742-746.
   PubMed Web of Science ®Google Scholar
• GÖBEL H, LINDNER V, KRACK P et al.: Treatment of chronic tension-type headache with botulinum toxin. Cephalalgia (1999) 19:455.
   Web of Science ®Google Scholar
• SMUTS JA, BAKER MK, SMUTS HM et al.: Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur. J. Neurol. (1999) 6(Suppl. 4):99-102.
   Google Scholar
• ROLLNIK JD, TANNEBERGER O, SCHUBERT M et al.: Treatment of tension-type headache with botulinum toxin A: a double-blind, placebo-controlled study. Headache (2000) 40:300-305.
   PubMed Web of Science ®Google Scholar
• BURCH CM, KOKOSKA MS, GLASER DA, HOLLENBEAK CS: Treatment of frontal tension headaches with botulinum toxin A. Cephalalgia (2001) 21:489.
   Google Scholar
• SCHMITT WJ, SLOWEY E, FRAVI N et al.: Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache (2001) 41:658-664.
   PubMed Web of Science ®Google Scholar
• SCHULTE-MATTLER W, KRACK P, BoNTTH STUDY GROUP: Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Pain (2004) 109:110-114.
   PubMed Web of Science ®Google Scholar
• KOKOSKA MS, GLASER DA, BURCH CM, HOLLENBEAK CS: Botulinum toxin injections for the treatment of frontal tension headache. J. Headache Pain (2004) 5:103-109.
   Google Scholar
• PADBERG M, DE BRUIJN SFTM, DE HAAN RJ, TAVY DLJ: Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia (2004) 24:675-680.
   PubMed Web of Science ®Google Scholar
• EMPL M, CEBALLOS-BAUMANN A, TÖLLE T et al.: Treatment of chronic tension-type headache with botulinum toxin A (Dysport®): a double-blind multicentre study. J. Neurol. (2005) 252(Suppl. 2):II/61-II/62.
   Google Scholar
• SILBERSTEIN SD, GÖBEL H, JENSEN R et al.: Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicenter, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia (2006) 26(7):790-800.
   PubMed Web of Science ®Google Scholar
• RELJA MA, KLEPAC N: Botulinum toxin A as prophylactic treatment in chronic tension-type headache: long-term follow-up study. Neurology (2001) 56(Suppl. 3):A349-A350.
   Google Scholar
• HEADACHE CLASSIFICATIONCOMMITTEE OF THE INTERNATIONAL HEADACHE SOCIETY: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia (1988) 8(Suppl. 7):1-92.
   Web of Science ®Google Scholar
• HEADACHE CLASSIFICATIONSUBCOMMITTEE OF THE INTERNATIONAL HEADACHE SOCIETY: International classification of headache disorders, 2nd edition. Cephalalgia (2004) 24(Suppl. 1):1-160.
   Web of Science ®Google Scholar
• BRIN MF, SWOPE DM, O’BRIAN C et al.: Botox® for migraine: double-blind, placebo-controlled, region-specific evaluation. Cephalalgia (2000) 20:421-422.
   Google Scholar
• EVERS S, VOLLMER-HAASE J, SCHWAAG S, RAHMANN A, HUSSTEDT IW, FRESE A: Botulinum toxin A in the prophylactic treatment of migraine – a randomized, double-blind, placebo-controlled study. Cephalalgia (2004) 24:838-843.
   PubMed Web of Science ®Google Scholar
• SAPER JR, MATHEW NT, LODER EW et al.: A double-blind, randomised, placebo-controlled exploratory study comparing injection sites with low dose botulinum toxin type A in the prevention of episodic migraine. J. Neurol. (2005) 252(Suppl. 2):II/58.
   Google Scholar
• RELJA M, POOLE AC, SCHOENEN J et al.: A multicentre, double-blind, randomised, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of migraine headache. J. Neurol. (2005) 252(Suppl. 2):II/62.
   Google Scholar
• CHANKRACHANG S, ARAYAWICHANONT A, POUNGVARIN N et al.: Botulinum toxin type A in migraine without aura prophylaxis) a 12 week prospective, multicentre, double-blind, randomized, placebo-controlled trial. Cephalalgia (2005) 25:992-993.
   Google Scholar
• SILBERSTEIN S, MATHEW N, SAPER J, JENKINS S: Botulinum toxin type A as a migraine preventive treatment. Headache (2000) 40:445-450.
   PubMed Web of Science ®Google Scholar
• BARRIENTOS N, CHANA P: Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study. J. Headache Pain (2003) 4:146-151.
   Google Scholar
• ONDO WG, VUONG KD, DERMAN HS: Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study. Cephalalgia (2004) 24:60-65.
   PubMed Web of Science ®Google Scholar
• SILBERSTEIN SD, STARK SR, LUCAS SM et al.: Botulinum toxin type A for the prophylactic treatment of chronic daily hedache: a randomized, double-blind, placebo-controlled trial. Mayo Clin. Proc. (2005) 80:1126-1137.
   PubMed Web of Science ®Google Scholar
• MATHEW NT, FRISHBERG BM, GAWEL M, DIMITROVA RT, GIBSON J, TURKEL C: Botulinum toxin type A (Botox®) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache (2005) 45:293-307.
   PubMed Web of Science ®Google Scholar
• DODICK DW, MAUSKOP A, ELKIND AH et al.: Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache (2005) 45:315-324.
   PubMed Web of Science ®Google Scholar
• ELKIND AH, TURKEL CC: Botulinum toxin type A for the prophylaxis of headache in migraineurs with 16 days or more days of headache per 30 days: effect on frequency of all headache attacks and headaches of > 4 hours in duration (randomised, double-blind, placebo-controlled study). J. Neurol. (2005) 252:II/60.
   Google Scholar
• FREUND BJ, SCHWARTZ M: Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study. Headache (2000) 40:231-236.
   PubMed Web of Science ®Google Scholar
• SCHNIDER P, MORARU E, BITTNER C et al.: Physical therapy and botulinum toxin type A in patients with cervical associated headache according to IHS-criteria: double-blind placebo-controlled study. Neurology (2001) 56(Suppl. 3):A349.
   Google Scholar
• STOVNER LJ, ZWART JA, HAGEN K, TERWINDT GM, PASCUAL J: Epidemiology of headache in Europe. Eur. J. Neurol. (2006) 13:333-345.
   Google Scholar